In the current month, NUS has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. NUS average Analyst price target in the last month is 12.770.
Based on analysts' estimates, NUS EPS is projected to reach 0.210 in FY2026Q3, following reported EPS of -5.140 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -5.14, while NU Skin Enterprises IncNUS's earnings per share (EPS) for the previous quarter was USD 0.04. EPS for the next quarter is expected at USD 0.21.